Zhanjun Lu

Dr. Zhanjun Lu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2020 in Micromachines
Verified
Journal Article
Open access
PDF file
WLWei Li
Wei Li
XSXindi Sun
Xindi Sun
BJBing Ji
Bing Ji
XYXingyuan Yang
Xingyuan Yang
BZBingpu Zhou
Bingpu Zhou
XGXinghua Gao
Xinghua Gao
Lung-on-a-chip devices could provide new strategies for a biomimetic lung cell microenvironment and construction of lung disease models in vitro, and are expected to greatly promote the development of drug evaluation, toxicological detection, and disease model building. In this study, we developed a novel poly (lactic-co-glycolic acid) (PLGA) nanofiber/polydimethylsiloxane (PDMS) microporous composite membrane-sandwiched lung-on-a-chip to perform anti-tumor drug testing. The composite membrane was characterized, and the results showed that it was permeable to molecules and thus could be used to study small-molecule drug diffusion. In addition, the microchip could apply perfusion fluids to simulate blood flow under extremely low fluid shear stress, and could also simulate the spherical-like shape of the alveoli by deformation of the composite membrane. Using this chip, we evaluated the anti-tumor drug efficacy of gefitinib in two kinds of non-small cell lung cancer cells, the lung adenocarcinoma NCI-H1650 cell line and the large cell lung cancer NCI-H460 cell line. We further probed the resistance of NCI-H460 cells to gefitinib under normoxic and hypoxic conditions. The established composite membrane-sandwiched lung chip can simulate more biochemical and biophysical factors in the lung physiological and pathological microenvironment, and it has important applications in the personalized treatment of lung tumors. It is expected to play a potential role in clinical diagnosis and drug screening.

1 June 2014 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
YSYun-Na Song
Yun-Na Song
PZPing Zheng
Ping Zheng
JXJun-Hua Xiao
Jun-Hua Xiao
ZLZhanjun Lu
Zhanjun Lu

6 May 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
YHYangyang Hu
Yangyang Hu
JDJuanjuan Dai
Juanjuan Dai
GZGuanzhao Zong
Guanzhao Zong
JXJingbo Xiao
Jingbo Xiao
XGXingya Guo
Xingya Guo
RWRong Wan
Rong Wan

8 December 2023 in Journal of Innate Immunity
Verified
Journal Article
Open access
PDF file
HZHang Zhao
Hang Zhao
WLWenhua Li
Wenhua Li
XZXin Zhou
Xin Zhou
LPLiang Pan
Liang Pan
YFYun Feng
Yun Feng
ZLZhanjun Lu
Zhanjun Lu
Introduction: C-X-C motif chemokine ligand 1 (CXCL1) is a potent neutrophil chemoattractant that plays a pivotal role in recruiting neutrophils during inflammatory conditions. This study explored the role of CXCL1 in modulating the gut microbiota, influencing neutrophil infiltration, and contributing to the development of colitis. Methods: We employed quantitative PCR to assess CXCL1 expression in colon samples. A mouse model of dextran sulfate sodium (DSS)-induced colitis was utilized to explore the progression of colitis in wild-type (WT) and CXCL1-deficient (CXCL1−/−) mice. Results: Colitis attenuation was evident in CXCL1−/− mice. Significant alterations were observed in the gut microbiome, as revealed by 16S rRNA gene sequencing. Furthermore, CXCL1−/− mice exhibited reduced gut permeability and diminished endotoxin levels in peripheral blood following DSS treatment compared to WT mice. In response to DSS treatment, WT mice showed a clear increase in neutrophil infiltration, while CXCL1−/− mice exhibited lower levels of infiltration. Fecal microbiota transplantation (FMT) using stools from CXCL1−/− mice alleviated DSS-induced colitis. Interestingly, FMT from patients with colitis increased CXCL1 and Ly6G expression in the colons of gut-sterilized mice. Clinical data analysis revealed elevated CXCL1 and CD15 expression in patients with colitis, with a positive correlation between the severity of colitis and the expression of CXCL1 and CD15. Conclusion: These findings shed light on the pivotal role of CXCL1 in promoting colitis by modulating the gut microbiota.

29 September 2022 in Metals
Verified
Journal Article
Open access
PDF file
MHMeifeng He
Meifeng He
MWMingming Wang
Mingming Wang
KZKe Zhang
Ke Zhang
HWHaitao Wang
Haitao Wang
HJHong Jiang
Hong Jiang
ZLZhanjun Lu
Zhanjun Lu
Magnesium alloys have good biocompatibility because they have mechanical properties similar to those of human bones, are biodegradable, and release non-toxic corrosion products and ions in the human body. In this study, a new type of Mg70−xZn30Cex (x = 2, 4, 6, and 8) amorphous magnesium alloy was prepared by copper roller melt-spinning, and the corresponding mechanical properties and corrosion resistance were studied. The results showed that when x = 4 and 6, the Mg-Zn-Ce amorphous alloys had decent amorphous forming abilities. The addition of Ce could effectively improve the ductility of the magnesium-based amorphous alloys with an elastic modulus of each sample ranging between 30 and 58 GPa, which was similar to that of human bones; thus, these materials could effectively prevent the stress shielding effect caused by excessive elastic modulus after implantation. Additionally, the addition of an adequate amount of Ce significantly improved the corrosion resistance of the alloy. The experimental results showed that the best corrosion resistance of the magnesium-based amorphous alloys was achieved when x = 6.

30 November 2024 in Materials Chemistry and Physics
Verified
Journal Article
Closed access
HJHong Jiang
Hong Jiang
HLHang Liu
Hang Liu
HXHui Xing
Hui Xing
JTJiaojiao Tang
Jiaojiao Tang
ZLZhanjun Lu
Zhanjun Lu